Cargando…
Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
A novel coronavirus now known as SARS-CoV-2 emerged in late 2019, possibly following a zoonotic crossover from a coronavirus present in bats. This virus was identified as the pathogen responsible for the severe respiratory disease, coronavirus disease-19 (COVID-19), which as of May 2023, has killed...
Autor principal: | Samuel, Charles E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290182/ https://www.ncbi.nlm.nih.gov/pubmed/37364688 http://dx.doi.org/10.1016/j.jbc.2023.104960 |
Ejemplares similares
-
Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection
por: Fuentes-Prior, Pablo
Publicado: (2020) -
Role of host factors in SARS-CoV-2 entry
por: Evans, John P., et al.
Publicado: (2021) -
Phase separation by the SARS-CoV-2 nucleocapsid protein: Consensus and open questions
por: Cascarina, Sean M., et al.
Publicado: (2022) -
SARS-CoV-2–encoded ORF8 protein possesses complement inhibitory properties
por: Kumar, Jitendra, et al.
Publicado: (2023) -
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease
por: Noske, Gabriela Dias, et al.
Publicado: (2023)